Parallel Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Parallel Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-287	Closed	-$2K	–	3438
2021 Q3	$2K	Buy	+287	New	+$1.79K	﹤0.01%	2779

Parallel Advisors's FLXN Position: Q4 2021 in Review

Parallel Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 287 shares — an estimated $2K sold.

Parallel Advisors first reported a position in FLXN in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Parallel Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Parallel Advisors sold 287 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $2K.
Parallel Advisors first reported a position in Flexion Therapeutics, Inc. in Q3 2021 and held it in 1 quarter.
Parallel Advisors's Flexion Therapeutics, Inc. position peaked at $2K in Q3 2021.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Parallel Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.